Babar, Zara, and Areesha Babar. 2025. “FDA’s New Approval: Kisunla (Donanemab-Azbt) - A Major Breakthrough in Alzheimer’s Care”. Journal of the Pakistan Medical Association 75 (07):1156-56. https://doi.org/10.47391/JPMA.21951.